title: Plasma leucine kinetics and urinary nitrogen excretion in intensively treated diabetes mellitus.
abstract: It is well known that inadequate insulin therapy stimulates body protein loss in insulin-dependent diabetes mellitus (IDDM). It is less well known, however, that accelerated body protein loss (as indicated by increased leucine oxidation) occurs in IDDM even during conventional glycemic control. It is not known whether intensified insulin therapy fully normalizes protein oxidation or, more importantly, whether such therapy is sufficient to allow the adaptive decrease of protein oxidation that normally occurs when protein intake is restricted below the customary surfeit level. We used two measures of protein oxidation [daily urinary nitrogen (N) excretion over several days of intensive insulin therapy and plasma [1-13C]leucine oxidation during short-term strict euglycemia] to assess the response of 7 men with IDDM and 12 normal men after adaptation first to a control diet providing maintenance energy and conventional (surfeit) protein then to an isoenergetic protein-free diet. After adaptation to the protein-free diet and during short-term strict euglycemia achieved using intravenous insulin, leucine turnover and oxidation decreased equivalently in normal and diabetic subjects. However, daily urinary obligatory N excretion, which indicated the effect of the low-protein diet and intensive subcutaneous insulin therapy over several days, was increased by 18% in the diabetic group (P less than 0.05). Even mildly elevated average blood glucose values well within the guidelines for intensive therapy were strongly correlated with high rates of urinary N excretion (r = 0.97, P = 0.0002). Thus insulin therapy of IDDM that imposes strict euglycemia is compatible with a normal ability to diminish body protein oxidation in response to protein restriction.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: McGill Nutrition and Food Science Centre, McGill University, Montreal, Quebec, Canada.
authors.forename: F
authors.initials: F
authors.lastname: Larivière
authors.forename: D B
authors.initials: DB
authors.lastname: Kupranycz
authors.forename: J L
authors.initials: JL
authors.lastname: Chiasson
authors.forename: L J
authors.initials: LJ
authors.lastname: Hoffer
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D003404:Creatinine / Q000652:urine; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy / Q000652:urine; D004044:Dietary Proteins / Q000008:administration & dosage; D006706:Homeostasis; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007700:Kinetics; D007930:Leucine / Q000097:blood*; D008297:Male; D009584:Nitrogen / Q000652:urine*
chemical_list: D001786:Blood Glucose; D004044:Dietary Proteins; D007328:Insulin; D003404:Creatinine; D007930:Leucine; D009584:Nitrogen